PTPI (PTPI) Stock Price & Analysis
PTPI (PTPI) rose 20.00% to USD 0.01 as of September 8, 2026 at 13:20 UTC, according to Nexqual real-time market data.
PTPI last closed at USD 0.01; the session ranged USD 0.01–0.01 on volume of 126,002 shares. Market capitalization is —, with a 52-week range of USD 0–0.03 (PNK). Source: Nexqual, September 8, 2026 at 13:20 UTC.
Key Statistics (as of September 8, 2026 at 13:20 UTC)
| Price | USD 0.01 |
|---|---|
| Change | ▲ 20.00% (up) |
| Previous Close | USD 0.01 |
| Open | USD 0.01 |
| Day Range | USD 0.01 – 0.01 |
| 52-Week Range | USD 0 – 0.03 |
| Volume | 126,002 shares |
| Market Cap | — |
| Exchange | PNK |
Technical Analysis (PTPI)
Nexqual's technical model rates PTPI "BUY" based on 5 bullish and 1 bearish signals across 128 daily candles, as of September 8, 2026 at 13:20 UTC.
| Overall Signal | BUY |
|---|---|
| RSI (14) | 76.7 (overbought) |
| vs SMA50 | Above (USD 0) |
| MACD | 0 (positive) |
Earnings (PTPI)
Recent Earnings History
| Quarter | Actual vs Estimate |
|---|---|
| 2024-09-30 | USD -13.25 vs est -7.25 ▼ miss |
| 2024-06-30 | USD -9.25 vs est -19.25 ▲ beat |
| 2024-03-31 | USD -42.25 vs est -36 ▼ miss |
| 2023-12-31 | USD -54.25 vs est -27.75 ▼ miss |
Source: Nexqual, September 8, 2026 at 13:20 UTC.
Financials & Fundamentals (PTPI)
| Gross Margin | +0.00% |
|---|---|
| Operating Margin | +0.00% |
| Profit Margin | +0.00% |
| ROE | -124.40% |
| Current Ratio | 1.25 |
| Total Cash | $3.49M |
| Total Debt | $0 |
| Free Cash Flow | $-1.82M |
Source: Nexqual, September 8, 2026 at 13:20 UTC.
Ownership (PTPI)
| Insider Ownership | +24.08% |
|---|---|
| Institutional Ownership | +10.24% |
| Shares Outstanding | 42.37M |
| Float | 28.93M |
| Short % of Float | +25.07% |
Source: Nexqual, September 8, 2026 at 13:20 UTC.
From PTPI's Latest SEC 10-K Filing (filed 2026-04-15)
Source: SEC EDGAR 10-K. Curated by Nexqual.
Peers & Related Stocks
| Symbol | Name | Price | Change |
|---|---|---|---|
| BFRI | Biofrontera Inc. | USD 1.61 | ▲ 5.92% |
| ISPC | iSpecimen Inc. | USD 1.54 | ▲ 3.36% |
| KTTA | Pasithea Therapeutics Corp. | USD 0.58 | ▲ 0% |
| ENSC | Ensysce Biosciences, Inc. | USD 0.46 | ▲ 2.93% |
| LGVN | Longeveron Inc. | USD 6.81 | ▲ 0.44% |
Data source: Nexqual — real-time market data, technical indicators, analyst consensus, earnings, SEC EDGAR filings. Last updated: September 8, 2026 at 13:20 UTC. This page is informational and not investment advice.